Apo2L/TRAIL

You have access
Nitric Oxide Inhibits NF-κB-mediated Survival Signaling: Possible Role in Overcoming TRAIL Resistance
JOSEPH A. BAUER, JOSEPH A. LUPICA, JOSEPH A. DIDONATO and DANIEL J. LINDNER

Anticancer Research December 2020, 40 (12) 6751-6763; DOI: https://doi.org/10.21873/anticanres.14698
You have access
Doxorubicin Overcomes Resistance to Drozitumab by Antagonizing Inhibitor of Apoptosis Proteins (IAPs)
IRENE ZINONOS, AGATHA LABRINIDIS, VASILIOS LIAPIS, SHELLEY HAY, VASILIOS PANAGOPOULOS, MARK DENICHILO, VLADIMIR PONOMAREV, WENDY INGMAN, GERALD J. ATKINS, DAVID M. FINDLAY, ANDREW C.W. ZANNETTINO and ANDREAS EVDOKIOU

Anticancer Research December 2014, 34 (12) 7007-7020;

Main menu